Insufficient scRNA-seq data for expression of HSD3B2 at single-cell level.
Insufficient scRNA-seq data for expression of HSD3B2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 155134.42 | 258 / 258 | 56% | 318.10 | 129 / 230 |
kidney | 97% | 66.65 | 86 / 89 | 14% | 0.28 | 128 / 901 |
liver | 97% | 42.30 | 219 / 226 | 5% | 0.15 | 19 / 406 |
ovary | 86% | 82.54 | 154 / 180 | 11% | 0.52 | 46 / 430 |
intestine | 70% | 817.86 | 680 / 966 | 11% | 0.53 | 59 / 527 |
spleen | 78% | 18.63 | 187 / 241 | 0% | 0 | 0 / 0 |
bladder | 71% | 16.52 | 15 / 21 | 3% | 0.12 | 15 / 504 |
stomach | 64% | 19.80 | 229 / 359 | 8% | 0.38 | 24 / 286 |
prostate | 71% | 19.64 | 174 / 245 | 0% | 0.01 | 1 / 502 |
uterus | 69% | 27.03 | 118 / 170 | 0% | 0.03 | 2 / 459 |
pancreas | 68% | 17.54 | 224 / 328 | 1% | 2.05 | 1 / 178 |
breast | 67% | 14.70 | 308 / 459 | 1% | 3.18 | 16 / 1118 |
adipose | 64% | 15.78 | 773 / 1204 | 0% | 0 | 0 / 0 |
thymus | 54% | 16.23 | 354 / 653 | 2% | 0.05 | 13 / 605 |
esophagus | 49% | 13.59 | 712 / 1445 | 5% | 0.35 | 10 / 183 |
skin | 51% | 14.18 | 918 / 1809 | 3% | 7.58 | 13 / 472 |
blood vessel | 45% | 26.82 | 600 / 1335 | 0% | 0 | 0 / 0 |
lung | 43% | 9.97 | 248 / 578 | 1% | 0.38 | 11 / 1155 |
heart | 38% | 13.97 | 328 / 861 | 0% | 0 | 0 / 0 |
brain | 38% | 15.38 | 1004 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 29% | 11.17 | 268 / 929 | 0% | 0 | 0 / 0 |
muscle | 27% | 6.11 | 213 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021766 | Biological process | hippocampus development |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0008207 | Biological process | C21-steroid hormone metabolic process |
GO_0006702 | Biological process | androgen biosynthetic process |
GO_0051412 | Biological process | response to corticosterone |
GO_0005730 | Cellular component | nucleolus |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0045171 | Cellular component | intercellular bridge |
GO_0030868 | Cellular component | smooth endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0003854 | Molecular function | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity |
GO_0004769 | Molecular function | steroid delta-isomerase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
Gene name | HSD3B2 |
Protein name | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II) (3-beta-HSD II) (3-beta-HSD adrenal and gonadal type) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)] |
Synonyms | HSDB3B |
Description | FUNCTION: 3-beta-HSD is a bifunctional enzyme, that catalyzes the oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids. . |
Accessions | ENST00000369416.4 [P26439-1] Q5QP01 ENST00000433745.5 ENST00000543831.5 [P26439-1] P26439 |